Replies to post #21887 on Charlotte's Web Holdings Inc (CWBHF)

[DarthYoda]

Well, whaddya know. FDA grants orphan drug status for a CBD formulation to protect from a very popular "vaccine" side effect, based on the NLRP3 inflammasome I posted about a couple weeks ago..."Cannabidiol Formulation Granted Orphan Drug Designation for Pericarditis":
February 15, 2024

The Food and Drug Administration (FDA) has granted Orphan Drug designation to CardiolRx™ (cannabidiol oral solution) for the treatment of recurrent pericarditis. The NLRP3 inflammasome is known to play a key role in the inflammation and fibrosis associated with pericarditis.

https://www.empr.com/home/news/drugs-in-the-pipeline/cannabidiol-formulation-granted-orphan-drug-designation-for-pericarditis/
"The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD":
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173751754